Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03825549 · ClinicalTrials.gov registry record · NA
A Randomized Trial of Behavioral Economic Approaches to Reduce Unnecessary Opioid Prescribing
A NA study, sponsored by University of Pennsylvania.
- Completed
- Registry status
- NA
- Development phase
- 452
- Enrollment target
NCT03825549: Completed NA study, sponsored by University of Pennsylvania.
NCT03825549 is a NA study that has completed, run by University of Pennsylvania. The registered enrollment target is 452 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (68% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03825549, a NA study, has completed, sponsored by University of Pennsylvania.
- COMPLETED
- Registry status
- NA
- Development phase
- 452 participants
- Enrollment target
Study Summary
In this study, the investigators will evaluate the effect of a health system initiative aiming to change clinician opioid prescribing behaviors using two behavioral economic interventions - individual audit feedback and peer comparison feedback of clinicians.
Primary Outcome
The primary outcome is the change in the mean number of pills prescribed per opioid prescription from baseline to the intervention period.
Interventions
- BEHAVIORAL Individual audit feedback
- BEHAVIORAL Peer comparison feedback
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 452 participants |
| Start Date | 2019-09-03 |
| Est. Completion | 2020-03-02 |
| Phase | NA |
What the finished NCT03825549 record still lists
NCT03825549 is an interventional study that assigns participants to a tested intervention. The registered 452 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (68% lower).
The record links to 0 conditions, and to 2 interventions - of which Individual audit feedback is the first listed.
NCT03825549 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03825549 about?
NCT03825549 is a clinical study titled "A Randomized Trial of Behavioral Economic Approaches to Reduce Unnecessary Opioid Prescribing". In this study, the investigators will evaluate the effect of a health system initiative aiming to change clinician opioid prescribing behaviors using two behavioral economic interventions - individual audit feedback and peer comparison feedback of clinicians.
What is the current status of trial NCT03825549?
This trial is currently completed. It is a NA study. The enrollment target is 452 participants. The study started on 2019-09-03. Estimated completion is 2020-03-02.
What interventions are being tested in trial NCT03825549?
The interventions under investigation include: Individual audit feedback (BEHAVIORAL), Peer comparison feedback (BEHAVIORAL).
Who is sponsoring clinical trial NCT03825549?
This trial is sponsored by University of Pennsylvania, which has 1,423 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03825549's enrollment target sits among peer trials
452 225th of 2000 higher than 1,776 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05676255 · 452 participants · Phase 2
The Breast Cancer Survivors and Partners Online Research Together (SUPORT) Project
- NCT05703178 · 452 participants · Phase 3
Web-based Pain Coping Skills Training for Breast Cancer Survivors With AI-Associated Arthralgia
- NCT03460977 · 453 participants · Phase 1
A Study of Mevrometostat for Treatment of Relapsed/Refractory SCLC, Castration Resistant Prostate Cancer, and Follicular Lymphoma
- NCT04708171 · 453 participants
The PROGRAM-study: Awake Mapping Versus Asleep Mapping Versus No Mapping for Glioblastoma Resections
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI